Exact Mass: 708.3122
Exact Mass Matches: 708.3122
Found 112 metabolites which its exact mass value is equals to given mass value 708.3122
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Scillipheosidin 3-[glucosyl-(1->2)-rhamnoside]
Scillipheosidin 3-[glucosyl-(1->2)-rhamnoside] is found in fruits. Scillipheosidin 3-[glucosyl-(1->2)-rhamnoside] is a constituent of the seeds of Tamarindus indica (tamarind). Constituent of the seeds of Tamarindus indica (tamarind). Scillipheosidin 3-[glucosyl-(1->2)-rhamnoside] is found in fruits.
[(2R,3S,4S,5R,6S)-3,4-dihydroxy-6-[4-[3-(4-hydroxy-3-methoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-6-yl]-2-methoxyphenoxy]-5-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]methyl acetate
17alpha-digitoxigenin beta-D-glucos-3-ulosyl-(1->4)-alpha-L-thevetoside
1??,2??,6??-Triacetoxy-8??-isobutanoyloxy-9??-(??-furancarbonyloxy)-13-(??-methyl)butanoyloxy-4??-hydroxy-??-dihydroagarofuran
scillarenin-3-O-beta-D-glucosido-(1-4)-beta-D-glucoside
beta-D-cymaropyranosyl-(1->4)-O-beta-D-cymaropyranosyl-(1->4)-O-beta-D-canaropyranosyl-(1->4)-O-beta-D-digitoxopyranosyl-(1->4)-O-oleandro-1,5-lactone|perifosaccharide B
3beta-(O4-beta-D-Glucopyranosyl-alpha-L-rhamnopyranosyloxy)-12beta,14-dihydroxy-14beta-bufa-4,20,22-trienolid|3beta-(O4-beta-D-glucopyranosyl-alpha-L-rhamnopyranosyloxy)-12beta,14-dihydroxy-14beta-bufa-4,20,22-trienolide|glucoscilliphaeoside
Scillipheosidin 3-[glucosyl-(1->2)-rhamnoside]
Bastaxanthin F
2-Dicyclohexylphosphino-2,4,6-triisopropylbiphenyl gold(I) chloride
(R)-2,2,3,3-Tetrahydro-6,6-bis([1,1:3,1-terphenyl]-5-yl)-1,1-spirobi[1H-indene]-7,7-diol,99e.e.
(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-hydroxypropanoyl]amino]-2-(4-hydroxyphenyl)acetic acid
ManA4Acbeta1-3FucNAcalpha1-3DFucNAcalpha-O[CH2]3NH2
BIO-1211
BIO-1211 is a highly selective and orally active α4β1 (VLA-4) inhibitor, with IC50 values of 4 nM and 2 μM for α4β1 and α4β7, respectively[1][2][3].
(2s,3r,4s,5s,6r)-2-{4-[(1z,3s)-3-(4-{[(2s,3r,4s,5s,6r)-6-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}phenyl)penta-1,4-dien-1-yl]phenoxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(1s,4as,6s,7r,7as)-6-(acetyloxy)-7-[(acetyloxy)methyl]-4-({[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2z)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}oxan-2-yl]oxy}methyl)-7-hydroxy-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl 3-methylbutanoate
(1s,4as,6r,7r,7as)-6-(acetyloxy)-7-[(acetyloxy)methyl]-4-({[(2s,3s,4r,5r,6s)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2z)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}oxan-2-yl]oxy}methyl)-7-hydroxy-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl 3-methylbutanoate
(1s,4ar,7s,7as)-1-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-3-{[(2e,6e)-8-hydroxy-2,6-dimethylocta-2,6-dienoyl]oxy}-6-(hydroxymethyl)oxan-2-yl]oxy}-4-formyl-4a-hydroxy-7-methyl-1h,5h,6h,7ah-cyclopenta[c]pyran-7-yl (2e,6e)-8-hydroxy-2,6-dimethylocta-2,6-dienoate
(1s,2s,3r,4s,7r,9s,10s,11s,12r,15s)-4,9,11,12,15-pentakis(acetyloxy)-1-hydroxy-10,14,17,17-tetramethyl-6-oxatetracyclo[11.3.1.0³,¹⁰.0⁴,⁷]heptadec-13-en-2-yl hexanoate
(1r,2s,3r,4s,7r,9s,10s,11r,12r,15s)-4,9,11,12,15-pentakis(acetyloxy)-1-hydroxy-10,14,17,17-tetramethyl-6-oxatetracyclo[11.3.1.0³,¹⁰.0⁴,⁷]heptadec-13-en-2-yl hexanoate
(1r,2r,3ar,5r,9s,10r,11s,13r,13as)-1,3a,9,10,13-pentakis(acetyloxy)-2,5,8,8-tetramethyl-12-methylidene-11-(2-methylpropoxy)-4-oxo-1h,3h,5h,9h,10h,11h,13h,13ah-cyclopenta[12]annulen-2-yl acetate
6-(acetyloxy)-7-[(acetyloxy)methyl]-7-hydroxy-4-({[3,4,5-trihydroxy-6-({[3-(4-hydroxyphenyl)prop-2-enoyl]oxy}methyl)oxan-2-yl]oxy}methyl)-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl 3-methylbutanoate
(1s,4as,6s,7r,7as)-6-(acetyloxy)-7-[(acetyloxy)methyl]-4-({[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}oxan-2-yl]oxy}methyl)-7-hydroxy-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl 3-methylbutanoate
4-{[(2e)-6-{[(6e)-3-hydroxy-2,6-dimethyl-8-({7-oxofuro[3,2-g]chromen-4-yl}oxy)oct-6-en-2-yl]oxy}-3,7-dimethylocta-2,7-dien-1-yl]oxy}furo[3,2-g]chromen-7-one
5-[(1r,3as,3br,7s,9ar,9bs,11r,11as)-7-{[(2r,3r,4s,5r,6s)-3,4-dihydroxy-6-methyl-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3a,11-dihydroxy-9a,11a-dimethyl-1h,2h,3h,3bh,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]pyran-2-one
14-demethyl-14-isobutyrylanhweidelphinine
{"Ingredient_id": "HBIN001403","Ingredient_name": "14-demethyl-14-isobutyrylanhweidelphinine","Alias": "NA","Ingredient_formula": "C38H48N2O11","Ingredient_Smile": "CC1CC(=O)N(C1=O)C2=CC=CC=C2C(=O)OCC34CCC(C56C3C(C(C5N=C4)(C7(CC(C8CC6C7C8OC(=O)C(C)C)OC)O)O)OC)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5082","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
1α,2α,6β-triacetoxy-8β-isobutanoyloxy-9β-(β-furancarbonyloxy)-13-(α-methyl)butanoyloxy-4β-hydroxy-β-dihydroagarofuran
{"Ingredient_id": "HBIN002272","Ingredient_name": "1\u03b1,2\u03b1,6\u03b2-triacetoxy-8\u03b2-isobutanoyloxy-9\u03b2-(\u03b2-furancarbonyloxy)-13-(\u03b1-methyl)butanoyloxy-4\u03b2-hydroxy-\u03b2-dihydroagarofuran","Alias": "NA","Ingredient_formula": "C35H48O15","Ingredient_Smile": "CCC(C)C(=O)OCC12C(C(CC(C13C(C(C(C2OC(=O)C4=COC=C4)OC(=O)C(C)C)C(O3)(C)C)OC(=O)C)(C)O)OC(=O)C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21510","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}